ShockWave Medical, Inc.
Acquired
Matched to this startup by its exact name; the buyer's report is the source.
| Acquired | Buyer | Acquisition date | Completion | Price | Stake | Source |
|---|---|---|---|---|---|---|
| Shockwave Medical, Inc | Johnson & Johnson | 2024 | — | $12.6 B | — | Annual report |
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Mar 2019 | $10 M | No. 4 | $10 to $50 million | equity | SEC | |
| Dec 2018 | $15 M | No. 3 | $10 to $50 million | equity | SEC | |
| Nov 2016 | $80 M | No. 2 | $50 to $250 million | equity | SEC | |
| May 2015 | $40 M | No. 1 | $10 to $50 million | equity, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
ShockWave Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2019).
SEC Form D · Mar 2019
The industry group it chose in its notices: Other Health Care.
SEC Form D · Mar 2019
That is all the official record says: ShockWave Medical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
14 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Deerfield Management Company, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| Deerfield Mgmt III, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| Deerfield Mgmt L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| Deerfield Private Design Fund III, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| Deerfield Special Situations Fund, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| Frank T. Watkins | Person | not stated | not stated | Held Series A-1 and B preferred stock, director (Form 3, 2019) | SEC Form 3 |
| Frederic H. Moll | Person | not stated | not stated | Held Series A, A-1, B and C preferred stock, director (Form 3, 2019) | SEC Form 3 |
| Sofinnova Capital VII FCPR | Fund or asset manager | not stated | not stated | Held Series A-1, B and C preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| Venrock Associates VII, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| Venrock Healthcare Capital Partners II, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| Venrock Management VII, LLC | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| Venrock Partners VII, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| VHCP Co-Investment Holdings II, LLC | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
| VHCP Management II, LLC | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2019) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 29 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Dan Puckett | Executive officer | Mar 2019 |
| Douglas Godshall | Executive officer | Mar 2019 |
| Isaac Zacharias | Executive officer | Mar 2019 |
| Dan H. Puckett | Executive officer | Oct 2017 |
| Doug Godshall | Executive officer | Oct 2017 |
| Daniel Hawkins | Executive officer | Nov 2016 |
| Antoine Papiernik | Director | Mar 2019 |
| Colin Cahill | Director | Mar 2019 |
| Douglas Godshall | Director | Mar 2019 |
| Frederic Moll | Director | Mar 2019 |
| Jay Watkins | Director | Mar 2019 |
| Laura Francis | Director | Mar 2019 |
| Raymond Larkin | Director | Mar 2019 |
| Marc-Andre Marcotte | Director | Dec 2018 |
| Todd Brinton | Director | Dec 2018 |
| Antoine H. Papiernik | Director | Oct 2017 |
| Colin H. Cahill | Director | Oct 2017 |
| Doug Godshall | Director | Oct 2017 |
| Frederic H. Moll | Director | Oct 2017 |
| Jay H. Watkins | Director | Oct 2017 |
| Michael H. Sjostrom | Director | Oct 2017 |
| Todd J. Brinton | Director | Oct 2017 |
| Daniel Hawkins | Director | Nov 2016 |
Acquired (Jan 1, 2024). Acquired by Johnson & Johnson.